In:
Alzheimer's & Dementia: Translational Research & Clinical Interventions, Wiley, Vol. 6, No. 1 ( 2020-01)
Abstract:
In an attempt to capture clinically meaningful cognitive decline in early dementia, we developed the Cognitive‐Functional Composite (CFC). We investigated the CFC's sensitivity to decline in comparison to traditional clinical endpoints. Methods This longitudinal construct validation study included 148 participants with subjective cognitive decline, mild cognitive impairment, or mild dementia. The CFC and traditional tests were administered at baseline, 3, 6, and 12 months. Sensitivity to change was investigated using linear mixed models and r 2 effect sizes. Results CFC scores declined over time ( β = −.16, P 〈 .001), with steepest decline observed in mild Alzheimer's dementia ( β = −.25, P 〈 .001). The CFC showed medium‐to‐large effect sizes at succeeding follow‐up points ( r 2 = .08‐.42), exhibiting greater change than the Clinical Dementia Rating scale ( r 2 = .02‐.12). Moreover, change on the CFC was significantly associated with informant reports of cognitive decline ( β = .38, P 〈 .001). Discussion By showing sensitivity to decline, the CFC could enhance the monitoring of disease progression in dementia research and clinical practice.
Type of Medium:
Online Resource
ISSN:
2352-8737
,
2352-8737
Language:
English
Publisher:
Wiley
Publication Date:
2020
detail.hit.zdb_id:
2832891-7
Permalink